Physician profile
Eunmee E Yook
NPI 1669715504
$6,301.59
in general payments reported to CMS, 2019-2025
13 companies · $1,544 in 2025
The $1,544 reported for 2025 was more than what 85% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $398 · 2020: $1,125 · 2021: $464 · 2022: $715 · 2023: $753 · 2024: $1,303 · 2025: $1,544.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,600.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,599.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,710.48 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Allergan, INC. | $1,401.93 | 2019-2022 | |
| Alcon Vision LLC | $969.19 | 2022-2025 | Rocklatan, Hydrus Microstent, Unity |
| Glaukos Corporation | $951.22 | 2021-2025 | Idose, Istent Trabecular Micro-Bypass System Model Is3, Idosetr |
| New World Medical,INC. | $570.26 | 2022-2025 | Kahook Dual Blade, Ahmed Glaucoma Valve, Streamline |
| Aerie Pharmaceuticals, INC. | $302.04 | 2019-2021 | |
| Ivantis, INC | $143.49 | 2021 | |
| Bausch & Lomb Americas INC. | $104.25 | 2022-2025 | Miebo, Vyzulta |
| Thea Pharma INC. | $61.37 | 2024-2025 | Iyuzeh |
| Sight Sciences, INC. | $25.70 | 2024 | Omni Surgical System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $23.46 | 2020 | |
| Dompe US, INC. | $22.64 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $15.56 | 2025 | Xdemvy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eunmee Yook listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.